Dalpiciclib Isetionate Tablets

DRUG2 trials

Sponsors

Risen (Suzhou) Pharma Tech Co., Ltd., Sun Yat-sen University

Conditions

Advanced Solid TumorsHepatocellulcar Carcinoma

Phase 1

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

RecruitingNCT06208410

Risen (Suzhou) Pharma Tech Co., Ltd.Advanced Solid Tumors

Start: 2024-01-11End: 2027-02-26Target: 306Updated: 2025-07-25

Phase 2

Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment

RecruitingNCT07238881

Sun Yat-sen UniversityHepatocellulcar Carcinoma

Start: 2025-11-05End: 2027-06-01Target: 30Updated: 2025-11-20